Last reviewed · How we verify

NCT04242641: WWChild

An Exploratory Study to Determine the Potential Impact of Parental Attendance at WW on Weight and Behavioural Outcomes in Children: WWChild

Terminated NA Last updated 31 August 2021
What this trial tests

NA trial testing WW in Obesity, Childhood in 2 participants. Terminated before completion.

Timeline
24 January 2020
Primary endpoint
1 April 2020
1 April 2020

Quick facts

Lead sponsorUniversity of Leeds
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment2
Start date24 January 2020
Primary completion1 April 2020
Estimated completion1 April 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Leeds

Who can join

Adults 5 to 75, any sex, with Obesity, Childhood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the WWChild study is to determine the feasibility of assessing the potential impact of parents attendance at WW on their child's weight status and weight related behaviours. The feasibility study will randomly allocate 60 parent participants to either the WW programme (formally Weight Watchers) or to a control arm. Data will be collected from both parent and child at baseline and at three months to explore changes in weight status and weight related behaviours.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of WW

Trials testing the same drug.

Other recruiting trials for Obesity, Childhood

Currently open trials in the same condition.

Other University of Leeds trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing